Bio-Works Technologies AB (BIOWKS) — Cash Flow Quality Index

Latest as of June 2021: 1.05x

Bio-Works Technologies AB (BIOWKS) has a Cash Flow Quality Index of 1.05x as of June 2021. Operating cash flow of Skr9.35 Million exceeds net income of Skr8.88 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Bio-Works Technologies AB to assess how effectively this company generates cash.

Cash Flow Quality Index

1.05x

Operating CF / Net Income

Operating Cash Flow

Skr9.35 Million

SEK

Net Income

Skr8.88 Million

SEK

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for Bio-Works Technologies AB (None–None)

Year-by-year earnings quality comparison for Bio-Works Technologies AB. For live market cap and the full company financial profile, see Bio-Works Technologies AB market cap and net worth.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.